Dashboard
Manage Tickers

LFVN Lifevantage Corp

Nasdaq lifevantage.com


$ 9.02 $ 0.10 (1.12 %)    

Monday, 13-Oct-2025 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 595.57 $ 0.00 (0 %)
DIA $ 458.32 $ 0.00 (0 %)
SPY $ 657.43 $ 0.00 (0 %)
TLT $ 90.86 $ 0.00 (0 %)
GLD $ 381.00 $ 0.00 (0 %)
$ 9.06
$ 9.06
$ 8.88 x 3,000
$ 13.50 x 6
-- - --
$ 8.80 - $ 27.12
108,332
na
114.98M
$ 0.36
$ 11.73
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-04-2025 06-30-2025 10-K
2 05-06-2025 03-31-2025 10-Q
3 02-05-2025 12-31-2024 10-Q
4 10-29-2024 09-30-2024 10-Q
5 08-28-2024 06-30-2024 10-K
6 05-02-2024 03-31-2024 10-Q
7 01-30-2024 12-31-2023 10-Q
8 11-09-2023 09-30-2023 10-Q
9 08-28-2023 06-30-2023 10-K
10 05-04-2023 03-31-2023 10-Q
11 02-02-2023 12-31-2022 10-Q
12 11-02-2022 09-30-2022 10-Q
13 08-23-2022 06-30-2022 10-K
14 05-03-2022 03-31-2022 10-Q
15 02-01-2022 12-31-2021 10-Q
16 11-04-2021 09-30-2021 10-Q
17 08-19-2021 06-30-2021 10-K
18 04-29-2021 03-31-2021 10-Q
19 02-02-2021 12-31-2020 10-Q
20 11-03-2020 09-30-2020 10-Q
21 08-18-2020 06-30-2020 10-K
22 05-05-2020 03-31-2020 10-Q
23 01-28-2020 12-31-2019 10-Q
24 10-30-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-K
26 05-01-2019 03-31-2019 10-Q
27 02-04-2019 12-31-2018 10-Q
28 11-01-2018 09-30-2018 10-Q
29 08-15-2018 06-30-2018 10-K
30 05-09-2018 03-31-2018 10-Q
31 02-07-2018 12-31-2017 10-Q
32 11-08-2017 09-30-2017 10-Q
33 09-07-2017 06-30-2017 10-K
34 05-10-2017 03-31-2017 10-Q
35 02-08-2017 12-31-2016 10-Q
36 12-12-2016 06-30-2016 10-K
37 12-12-2016 09-30-2016 10-Q
38 05-04-2016 03-31-2016 10-Q
39 02-09-2016 12-31-2015 10-Q
40 11-04-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

correction-on-september-4-2025-lifevantage-reported-that-it-sees-fy2026-adj-eps-100-115-vs-100-est-sees-sales-225000m-240000m-vs-252400m-est
CORRECTION: On September 4, 2025 Lifevanta...
09/06/2025 16:03:59

Lifevantage (NASDAQ:LFVN) is looking for FY2026 Adj EPS of $1.00-$1.15 vs $1.00 analyst estimate. sees sales of $225.000 millio...

american-outdoor-brands-posts-downbeat-results-joins-lululemon-quanex-building-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
American Outdoor Brands Posts Downbeat Res...
09/05/2025 12:48:05

why-docusign-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket
Why Docusign Shares Are Trading Higher By ...
09/05/2025 09:20:59

lifevantage-q4-adj-eps-017-beats-015-estimate-sales-55114m-miss-56900m-estimate
Lifevantage Q4 Adj. EPS $0.17 Beats $0.15 ...
09/04/2025 20:05:51

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.15 by ...

Core News & Articles
Earnings Scheduled For September 4, 2025
09/04/2025 08:32:12

lifevantage-acquires-lovebiome-terms-not-disclosed
LifeVantage Acquires LoveBiome; Terms Not ...
09/03/2025 21:14:41

SALT LAKE CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company ...

whats-next-lifevantages-earnings-preview
What's Next: Lifevantage's Earnings Preview
09/03/2025 16:01:56

lifevantage-expands-human-clinical-study-for-mindbody-glp-1-system
LifeVantage Expands Human Clinical Study F...
07/22/2025 12:09:47

lifevantage-raises-fy2025-adj-eps-guidance-from-070-080-to-072-088-vs-078-est-lowers-fy2025-sales-guidance-from-23500m-24500m-to-22800m-23500m-vs-23974m-est
Lifevantage Raises FY2025 Adj EPS Guidance...
05/06/2025 20:15:01

Lifevantage (NASDAQ:LFVN) raises FY2025 Adj EPS guidance from $0.70-$0.80 to $0.72-$0.88 vs $0.78 analyst estimate. Lowers FY20...

lifevantage-q3-eps-026-beats-014-estimate-sales-5840m-miss-6096m-estimate
Lifevantage Q3 EPS $0.26 Beats $0.14 Estim...
05/06/2025 20:11:56

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.14 by ...

lifevantage-board-raises-quarterly-cash-dividend-by-125-to-from-004-to-0045-per-share
LifeVantage Board Raises Quarterly Cash Di...
05/06/2025 20:10:38

LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health ...

Core News & Articles
Earnings Scheduled For May 6, 2025
05/06/2025 08:32:41

why-reshape-lifesciences-shares-are-trading-higher-by-over-82-here-are-20-stocks-moving-premarket
Why ReShape Lifesciences Shares Are Tradin...
04/10/2025 09:26:21

Core News & Articles
FDA Says Novo Nordisk's Ozempic Injection ...
02/21/2025 14:22:44

earnings-breakdown-lifevantage-q2
Earnings Breakdown: Lifevantage Q2
02/05/2025 21:55:56

lifevantage-q2-earnings-insights
Lifevantage: Q2 Earnings Insights
02/05/2025 21:51:59

lifevantage-q2-earnings-assessment
Lifevantage Q2 Earnings Assessment
02/05/2025 21:45:47

lifevantage-earnings-report-q2-overview
Lifevantage Earnings Report: Q2 Overview
02/05/2025 21:40:40

lifevantage-affirms-fy2025-sales-guidance-from-23500m-24500m-to-23500m-24500m-vs-23848m-est
Lifevantage Affirms FY2025 Sales Guidance ...
02/05/2025 21:38:15

Lifevantage (NASDAQ:LFVN) affirms FY2025 sales outlook from $235.00 million-245.00 million to $235.00 million-245.00 million vs...

lifevantage-q2-adj-022-beats-013-estimate-sales-6776m-beat-6739m-estimate
Lifevantage Q2 Adj $0.22 Beats $0.13 Estim...
02/05/2025 21:37:29

Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.13 by ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION